Literature DB >> 24670017

Complications associated with postoperative adjuvant radiation therapy for advanced rectal cancer.

Koji Komori1, Kenya Kimura, Takashi Kinoshita, Tsuyoshi Sano, Seiji Ito, Tetsuya Abe, Yoshiki Senda, Kazunari Misawa, Yuichi Ito, Norihisa Uemura, Ryosuke Kawai, Yasuhiro Shimizu.   

Abstract

Preoperative management of advanced rectal cancer often includes chemoradiotherapy, but little is known about the late complications of radiotherapy. However, these are usually serious, making determination of the characteristics of late complications after radiation therapy critical. Accordingly, we investigated the complications occurring after adjuvant pelvic radiation therapy in patients with advanced rectal cancer. We enrolled 34 consecutive patients with TNM stage III rectal cancer who had undergone curative surgery with adjuvant pelvic radiation therapy. Data on the type of complication/organ involved, the number of complications, the phase of onset, and the treatments used were reviewed. Patients who experienced gut complications or edema were less likely to have their complications resolved than those with complications due to infection. Similarly, patients with multiple complications and late-onset complications were also less likely to have their complications resolved than those with single complications and those with early-onset complications, respectively. Adjuvant radiation therapy in patients with resected advanced rectal cancer was associated with various complications, characterized by late onset and impaired resolution. Therefore, patients indicated for radiation therapy should be selected with great caution.

Entities:  

Mesh:

Year:  2014        PMID: 24670017      PMCID: PMC3968833          DOI: 10.9738/INTSURG-D-13-00200.1

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  16 in total

1.  Late toxicity in complete response cases after definitive chemoradiotherapy for esophageal squamous cell carcinoma.

Authors:  Yosuke Kumekawa; Kazuhiro Kaneko; Hiroaki Ito; Toshinori Kurahashi; Kazuo Konishi; Atsushi Katagiri; Taikan Yamamoto; Meiko Kuwahara; Yutaro Kubota; Takashi Muramoto; Yoshihide Mizutani; Michio Imawari
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

Review 2.  Chemoradiotherapy and adjuvant chemotherapy for rectal cancer.

Authors:  Toshiaki Watanabe
Journal:  Int J Clin Oncol       Date:  2008-12-18       Impact factor: 3.402

3.  Late effects of post-high-dose-rate brachytherapy for oropharyngeal carcinoma: are they severer than post-low-dose-rate?

Authors:  Takayuki Nose; Didier Peiffert; Michel Lapeyre; Sylvette Hoffstetter; Masahiko Koizumi; Kinji Nishiyama
Journal:  Strahlenther Onkol       Date:  2004-12       Impact factor: 3.621

4.  Preliminary results of pelvic autonomic nerve-preserving surgery combined with intraoperative and postoperative radiation therapy for patients with low rectal cancer.

Authors:  S Ishikura; T Ogino; M Ono; T Arai; M Sugito; W Shimizu; M Kawashima; M Imai; Y Ito; H Ikeda
Journal:  Jpn J Clin Oncol       Date:  1999-09       Impact factor: 3.019

5.  Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus.

Authors:  Satoshi Ishikura; Keiji Nihei; Atsushi Ohtsu; Narikazu Boku; Shuichi Hironaka; Kiyomi Mera; Manabu Muto; Takashi Ogino; Shigeaki Yoshida
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544

6.  Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

Authors:  Thierry André; Corrado Boni; Matilde Navarro; Josep Tabernero; Tamas Hickish; Clare Topham; Andrea Bonetti; Philip Clingan; John Bridgewater; Fernando Rivera; Aimery de Gramont
Journal:  J Clin Oncol       Date:  2009-05-18       Impact factor: 44.544

7.  Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma.

Authors:  Madoka Morota; Kotaro Gomi; Takuyo Kozuka; Keisho Chin; Masaaki Matsuura; Masahiko Oguchi; Hisao Ito; Takashi Yamashita
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-26       Impact factor: 7.038

8.  Intraoperative radiotherapy for oncological and function-preserving surgery in patients with advanced lower rectal cancer.

Authors:  Tadahiko Masaki; Makoto Takayama; Hiroyoshi Matsuoka; Nobutsugu Abe; Hisayo Ueki; Masanori Sugiyama; Ayako Tonari; Junko Kusuda; Shinsaku Mizumoto; Yutaka Atomi
Journal:  Langenbecks Arch Surg       Date:  2008-01-03       Impact factor: 3.445

9.  Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapy.

Authors:  H Birgisson; L Påhlman; U Gunnarsson; B Glimelius
Journal:  Br J Surg       Date:  2008-02       Impact factor: 6.939

10.  Adjuvant postoperative radiotherapy in locally advanced rectal and rectosigmoidal cancer.

Authors:  R Zucali; G Gardani; F Volterrani
Journal:  Tumori       Date:  1980-10-31
View more
  8 in total

1.  Chemo-Radiation After Upfront Rectal Resections-a Clinical Dilemma.

Authors:  A Saklani; P Sugoor; M Bhandare; S Jatal; A Desouza; V Ostwal
Journal:  Indian J Surg Oncol       Date:  2018-08-18

2.  The use of artificial neural networks to predict delayed discharge and readmission in enhanced recovery following laparoscopic colorectal cancer surgery.

Authors:  N K Francis; A Luther; E Salib; L Allanby; D Messenger; A S Allison; N J Smart; J B Ockrim
Journal:  Tech Coloproctol       Date:  2015-06-19       Impact factor: 3.781

3.  The current status of emergency operations at a high-volume cancer center.

Authors:  Koji Komori; Kenya Kimura; Takashi Kinoshita; Seiji Ito; Tetsuya Abe; Yoshiki Senda; Kazunari Misawa; Yuichi Ito; Norihisa Uemura; Seiji Natsume; Ryosuke Kawai; Jiro Kawakami; Tomonari Asano; Yoshinori Iwata; Shintaro Kurahashi; Masayuki Tsutsuyama; Itaru Shigeyoshi; Yasuhiro Shimizu
Journal:  Int Surg       Date:  2014 Nov-Dec

4.  Incidence and predictors of prolonged postoperative ileus after colorectal surgery in the context of an enhanced recovery pathway.

Authors:  Mohsen Alhashemi; Julio F Fiore; Nadia Safa; Mohammed Al Mahroos; Juan Mata; Nicolò Pecorelli; Gabriele Baldini; Nandini Dendukuri; Barry L Stein; A Sender Liberman; Patrick Charlebois; Franco Carli; Liane S Feldman
Journal:  Surg Endosc       Date:  2018-10-17       Impact factor: 4.584

5.  Dosimetric comparative study of 3 different postoperative radiotherapy techniques (3D-CRT, IMRT, and RapidArc) for II-III stage rectal cancer.

Authors:  Min Liu; Bailong Liu; Huidong Wang; Lijuan Ding; Yinghua Shi; Chao Ge; Xu Su; Xiaodong Liu; Lihua Dong
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

6.  Influence of propofol intravenous anesthesia on hemorheology, haemodynamics and immune function of colorectal carcinoma patients undergoing radical resection.

Authors:  Jianmin Yu; Mingfen Han; Jun Geng
Journal:  Pak J Med Sci       Date:  2019       Impact factor: 1.088

7.  Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk.

Authors:  I-Li Lai; Jeng-Fu You; Yih-Jong Chern; Wen-Sy Tsai; Jy-Ming Chiang; Pao-Shiu Hsieh; Hsin-Yuan Hung; Chien-Yuh Yeh; Sum-Fu Chiang; Cheng-Chou Lai; Rei-Ping Tang; Jinn-Shiun Chen; Yu-Jen Hsu
Journal:  World J Surg Oncol       Date:  2019-12-09       Impact factor: 2.754

8.  Dosimetric comparison of organs at risk in 5 different radiotherapy plans in patients with preoperatively irradiated rectal cancer.

Authors:  Bekir Hakan Bakkal; Ozlem Elmas
Journal:  Medicine (Baltimore)       Date:  2021-01-08       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.